Digital Health Coffee Time Briefing āĀ
Today’s briefing covers trials into the use of psychoactive medicines to treat PTSD and academics calling for regulation of Femtech devices.
Back to Top
Today’s briefing covers trials into the use of psychoactive medicines to treat PTSD and academics calling for regulation of Femtech devices.
Applications have opened for the Evidence Generator Bootcamp from DigitalHealth.London, aimed at companies looking to enhance their evidence generation.
Alcidion has launched Miya Results Tracking in a bid to reduce the risk of test results not being followed up and thus improve patient safety.
Our latest Movers and Shakers roundup features plenty of movement within NHS England and a new chief executive for Health Innovation Kent Surrey Sussex.
Health leaders have given a cautious welcome to the Spring budget’s announcement of Ā£3.4 billion of investment in NHS digitisation.
Today’s briefing includes NHS England publishing guidance on network segmentation and Sonari Analytics and Candel Therapeutics announcing a partnership.
Access HSC managing director Steve Sawyer has said that it is āblinkeredā to solely look at and worry about EPRs because āit is not about the EPR anymoreā.
The company did not say why Mustafa Suleyman was taking time off, but said the
The trial aims to help develop, test and ultimately deploy artificial intelligence (AI) tools in
NHS Forth Valley confirmed to Digital Health News that the glitch occurred after updating their
More people are turning to Google to self-diagnose their boo-boos and ailments, with Londoners proving
The provider must ensure configuration to national screening systems and processes by 15 September, or